C. Gundogan Et Al. , "False-Positive 68Ga-Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient with Breast Cancer," Clinical Nuclear Medicine , vol.46, no.8, 2021
Gundogan, C. Et Al. 2021. False-Positive 68Ga-Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient with Breast Cancer. Clinical Nuclear Medicine , vol.46, no.8 .
Gundogan, C., Guzel, Y., Can, C., Alabalik, U., & Komek, H., (2021). False-Positive 68Ga-Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient with Breast Cancer. Clinical Nuclear Medicine , vol.46, no.8.
Gundogan, Cihan Et Al. "False-Positive 68Ga-Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient with Breast Cancer," Clinical Nuclear Medicine , vol.46, no.8, 2021
Gundogan, Cihan Et Al. "False-Positive 68Ga-Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient with Breast Cancer." Clinical Nuclear Medicine , vol.46, no.8, 2021
Gundogan, C. Et Al. (2021) . "False-Positive 68Ga-Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient with Breast Cancer." Clinical Nuclear Medicine , vol.46, no.8.
@article{article, author={Cihan Gundogan Et Al. }, title={False-Positive 68Ga-Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient with Breast Cancer}, journal={Clinical Nuclear Medicine}, year=2021}